Artificial Intelligence-Driven Algorithm for Drug Effect Prediction on Atrial Fibrillation: An in silico Population of Models Approach
Authors:
Open Access
- 6 December 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 12
Abstract
Background: Antiarrhythmic drugs are the first-line treatment for atrial fibrillation (AF), but their effect is highly dependent on the characteristics of the patient. Moreover, anatomical variability, and specifically atrial size, have also a strong influence on AF recurrence.Objective: We performed a proof-of-concept study using artificial intelligence (AI) that enabled us to identify proarrhythmic profiles based on pattern identification from in silico simulations.Methods: A population of models consisting of 127 electrophysiological profiles with a variation of nine electrophysiological variables (GNa, INaK, GK1, GCaL, GKur, IKCa, [Na]ext, and [K]ext and diffusion) was simulated using the Koivumaki atrial model on square planes corresponding to a normal (16 cm2) and dilated (22.5 cm2) atrium. The simple pore channel equation was used for drug implementation including three drugs (isoproterenol, flecainide, and verapamil). We analyzed the effect of every ionic channel combination to evaluate arrhythmia induction. A Random Forest algorithm was trained using the population of models and AF inducibility as input and output, respectively. The algorithm was trained with 80% of the data (N = 832) and 20% of the data was used for testing with a k-fold cross-validation (k = 5).Results: We found two electrophysiological patterns derived from the AI algorithm that was associated with proarrhythmic behavior in most of the profiles, where GK1 was identified as the most important current for classifying the proarrhythmicity of a given profile. Additionally, we found different effects of the drugs depending on the electrophysiological profile and a higher tendency of the dilated tissue to fibrillate (Small tissue: 80 profiles vs Dilated tissue: 87 profiles).Conclusion: Artificial intelligence algorithms appear as a novel tool for electrophysiological pattern identification and analysis of the effect of antiarrhythmic drugs on a heterogeneous population of patients with AF.Keywords
Funding Information
- Instituto de Salud Carlos III (PI16/01123, DTS16/0160, PI17/01059, PI18/01895, PI20/01618)
- Ministerio de Ciencia e Innovación (CIBERCV)
- European Regional Development Fund
- EIT Health (19600 AFFINE)
- Horizon 2020 Framework Programme (No. 874827)
This publication has 62 references indexed in Scilit:
- Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiologyProceedings of the National Academy of Sciences, 2013
- Determinants of myocardial conduction velocity: implications for arrhythmogenesisFrontiers in Physiology, 2013
- Application of cardiac electrophysiology simulations to pro‐arrhythmic safety testingBritish Journal of Pharmacology, 2012
- Dynamic reciprocity of sodium and potassium channel expression in a macromolecular complex controls cardiac excitability and arrhythmiaProceedings of the National Academy of Sciences, 2012
- Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigsCardiovascular Research, 2010
- The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implicationsCardiovascular Research, 2010
- Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell linesJournal of Clinical Investigation, 2009
- Atrial Remodeling and Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2008
- Arrhythmogenic Mechanisms in a Mouse Model of Catecholaminergic Polymorphic Ventricular TachycardiaCirculation Research, 2007
- Up‐regulation of the inward rectifier K+ current (IK1) in the mouse heart accelerates and stabilizes rotorsThe Journal of Physiology, 2006